Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3409525
Max Phase: Preclinical
Molecular Formula: C21H32Li2N3O7P
Molecular Weight: 471.49
Molecule Type: Small molecule
Associated Items:
ID: ALA3409525
Max Phase: Preclinical
Molecular Formula: C21H32Li2N3O7P
Molecular Weight: 471.49
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CCC(C)[C@H](NC(=O)[C@H](CC(C)C)NP(=O)([O-])CNC(=O)OCc1ccccc1)C(=O)[O-].[Li+].[Li+]
Standard InChI: InChI=1S/C21H34N3O7P.2Li/c1-5-15(4)18(20(26)27)23-19(25)17(11-14(2)3)24-32(29,30)13-22-21(28)31-12-16-9-7-6-8-10-16;;/h6-10,14-15,17-18H,5,11-13H2,1-4H3,(H,22,28)(H,23,25)(H,26,27)(H2,24,29,30);;/q;2*+1/p-2/t15?,17-,18-;;/m0../s1
Standard InChI Key: CUZJUZKTZGKWGP-HQBUKLJZSA-L
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 471.49 | Molecular Weight (Monoisotopic): 471.2134 | AlogP: 2.68 | #Rotatable Bonds: 13 |
Polar Surface Area: 154.06 | Molecular Species: ACID | HBA: 5 | HBD: 5 |
#RO5 Violations: 0 | HBA (Lipinski): 10 | HBD (Lipinski): 5 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 3.03 | CX Basic pKa: | CX LogP: 2.45 | CX LogD: -2.84 |
Aromatic Rings: 1 | Heavy Atoms: 32 | QED Weighted: 0.28 | Np Likeness Score: 0.07 |
1. Nasief NN, Hangauer D.. (2015) Additivity or cooperativity: which model can predict the influence of simultaneous incorporation of two or more functionalities in a ligand molecule?, 90 [PMID:25559080] [10.1016/j.ejmech.2014.11.056] |
Source(1):